CSIMarket Company Name, Ticker, Customers, else..


Intra cellular Therapies Inc   (NASDAQ: ITCI)
Other Ticker:  
 

Intra cellular Therapies Inc

ITCI's Fundamental analysis



Looking into Intra Cellular Therapies Inc growth rates, revenue grew by 50.81 % in the fourth quarter of 2024 from the same quarter a year ago. Ranking at No. 345

Major Pharmaceutical Preparations industry recorded growth of revenues by 11.77 %

Intra Cellular Therapies Inc net loss decreased from $-29 millions, to $-17 millions in fourth quarter of 2024,

• More on ITCI's Growth


Intra Cellular Therapies Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 85.92 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 20.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.


• More on ITCI's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 3,370,554
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.62
 Tangible Book Value (Per Share $) 11.07

Intra Cellular Therapies Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 85.92 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 20.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.17.

Intra Cellular Therapies Inc Price to Book Ratio is at 11.91 lower than Industry Avg. of 111.43. and higher than S&P 500 Avg. of 0.02

• More on ITCI's Valuation

•  Market Capitalization (Millions $) 13,677
•  Shares Outstanding (Millions) 104
•  Employees 202
•  Revenues (TTM) (Millions $) 681
•  Net Income (TTM) (Millions $) -75
•  Cash Flow (TTM) (Millions $) 159
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 3,370,554
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.62
•  Tangible Book Value (Per Share $) 11.07

•  Market Capitalization (Millions $) 13,677
•  Shares Outstanding (Millions) 104
•  Employees 202
•  Revenues (TTM) (Millions $) 681
•  Net Income (TTM) (Millions $) -75
•  Cash Flow (TTM) (Millions $) 159
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 6.36
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.19
•  Asset Turnover Ratio (TTM) 0.58
•  Inventory Turnover Ratio (TTM) -





Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.